U.S., Jan. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07357909) titled 'Safety Study of Intravenous Hydrogen-Oxygen Nanobubbles in Adults' on Dec. 30, 2025.
Brief Summary: The goal of this clinical trial is to learn whether hydrogen-oxygen nanobubbles can be safely given through a vein (intravenous infusion) to adults. This is a first-in-human study, meaning this type of infusion has not been tested in people before. The study focuses on safety and does not aim to treat or prevent any disease.
The main questions this study aims to answer are: 1) Can hydrogen-oxygen nanobubbles be given safely without causing serious or unacceptable side effects? 2) What dose range can be given safely to adults for futu...